News for Next Science Limited (NXS.AX)

Next Science shares fell -13% on Tuesday morning trades to 10cps as the company revealed it's received a warning letter from the FDA.

Next Science sued a former employee over breaching a non-compete clause; that employee counters with allegations of fraud. Uh oh.

Revenue: $22.2 million, up 89% year-on-year.Second Half FY '23 Revenue: $12.1 million.Direct Product Sales: $16.9 million, up 195%, representing 76% of total p

Feb 27, 2024 / 10:30PM GMTFrancoise Dixon - Next Science Ltd - Head of Investor Relations Good morning, everyone, and welcome to the Next Science Limited FY '23

Presenter SpeechFrançoise Dixon Textbox at the bottom of the screen, I'll now hand over to IV for the Q1 update.Presenter SpeechHarry Hall Thanks, Francois. Good morning, everyone, and thank you for...

Incannex Healthcare Inc (IXHL) has experienced a remarkable surge in its stock price, with an 800.00% gain over the past week and an impressive 519.15% increase

Incannex Healthcare Inc (IXHL) has experienced a remarkable surge in its stock price, with a 768.48% gain over the past week and an impressive 451.03% gain over

Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.19% to 6856.90.

The ASX is tracking higher in midday trade, up six per cent. Energy and utilities have been the biggest gainers so far.

Next Science (ASX:NXS) has appointed Harry Thomas Hall IV (I.V.) as its newest Managing Director and Chief Executive Officer.

Futures indicate the ASX will open higher on the last day of the trading week after a surge on Wall Street overnight.

The healthcare sector is ripe for disruption and artificial intelligence will play a big part in future drug discovery.

Will the 'spicy metal' bring the heat in 2023, three stocks with PGE potential, and how to invest in a hedge fund with $5K.

The ASX has finished the week down with small caps as Magnetite Mines leads the gains impressing investors with two strong announcements.

Explorers returns to Freo, can Resmed's dream run continue, and AVZ probably isn't listening to Robert Friedland right now.

The ASX has stumbled to -0.55% after the RBA hiked interest rates again, while EV Resources made some serious hay, up 46% on a $25m investment commitment.

The FDA declined regulate CBD-based supplements and food citing safety reasons, but the CBD index keeps going up.

Peregrine reckons it can go better than 122,497g/t, copper juniors ready to produce in 2023, and it's CPI week in Oz.

The ASX 200 gained 0.23% today and the ASX XEC was up 0.45% with 8 out of 11 sectors higher, led by Energy which rallied by 1.40%.